Amgen stock falls as analysts mull over weight loss drug’s bone density data – CNBC By Weight Loss Amgen stock falls as analysts mull over weight loss drug’s bone density data CNBC Brought to you by Google News. Read the rest of the article here Facebook Twitter Pinterest